These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 36634620)

  • 1. Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses.
    Morens DM; Taubenberger JK; Fauci AS
    Cell Host Microbe; 2023 Jan; 31(1):146-157. PubMed ID: 36634620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.
    Nagai M; Moriyama M; Ichinohe T
    mBio; 2021 Aug; 12(4):e0159821. PubMed ID: 34399617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in Mice.
    Chaparian RR; Harding AT; Hamele CE; Riebe K; Karlsson A; Sempowski GD; Heaton NS; Heaton BE
    J Virol; 2022 Aug; 96(15):e0068922. PubMed ID: 35862698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
    Ao Z; Ouyang MJ; Olukitibi TA; Warner B; Vendramelli R; Truong T; Meilleur C; Zhang M; Kung S; Fowke KR; Kobasa D; Yao X
    J Virol; 2022 Sep; 96(18):e0133722. PubMed ID: 36069551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice.
    Cao K; Wang X; Peng H; Ding L; Wang X; Hu Y; Dong L; Yang T; Hong X; Xing M; Li D; Zhu C; He X; Zhao C; Zhao P; Zhou D; Zhang X; Xu J
    J Virol; 2022 Feb; 96(4):e0157821. PubMed ID: 34908443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters.
    Deng S; Liu Y; Tam RC; Chen P; Zhang AJ; Mok BW; Long T; Kukic A; Zhou R; Xu H; Song W; Chan JF; To KK; Chen Z; Yuen KY; Wang P; Chen H
    Nat Commun; 2023 Apr; 14(1):2081. PubMed ID: 37045873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex Detection of Antibody Landscapes to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Influenza/Common Human Coronaviruses Following Vaccination or Infection With SARS-CoV-2 and Influenza.
    Li ZN; Liu F; Jefferson S; Horner L; Carney P; Johnson MDL; King JP; Martin ET; Zimmerman RK; Wernli K; Gaglani M; Thompson M; Flannery B; Stevens J; Tumpey T; Levine MZ
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S271-S284. PubMed ID: 35684961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
    Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases.
    Altenburg AF; Kreijtz JH; de Vries RD; Song F; Fux R; Rimmelzwaan GF; Sutter G; Volz A
    Viruses; 2014 Jul; 6(7):2735-61. PubMed ID: 25036462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bidirectional and persistent immunomodulation of Astragalus polysaccharide as an adjuvant of influenza and recombinant SARS-CoV-2 vaccine.
    Zhao D; Chen X; Wang L; Zhang J; Zhao Z; Yue N; Zhu Y; Fei W; Li X; Tan L; He W
    Int J Biol Macromol; 2023 Apr; 234():123635. PubMed ID: 36801224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections.
    Calzas C; Chevalier C
    Front Immunol; 2019; 10():1605. PubMed ID: 31379823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Vaccines and Drugs That Target the Surface Glycoproteins of Influenza Viruses, RSV, Parainfluenza Viruses, and SARS-CoV-2.
    Russell CJ; Govorkova EA
    Viruses; 2022 May; 14(6):. PubMed ID: 35746631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination.
    Kim Y; Zheng X; Eschke K; Chaudhry MZ; Bertoglio F; Tomić A; Krmpotić A; Hoffmann M; Bar-On Y; Boehme J; Bruder D; Ebensen T; Brunotte L; Ludwig S; Messerle M; Guzman C; Mandelboim O; Hust M; Pöhlmann S; Jonjić S; Čičin-Šain L
    Cell Mol Immunol; 2022 Feb; 19(2):234-244. PubMed ID: 34992275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets.
    Huang Y; Skarlupka AL; Jang H; Blas-Machado U; Holladay N; Hogan RJ; Ross TM
    J Virol; 2022 Mar; 96(5):e0179121. PubMed ID: 34936487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The disappearance of respiratory syncytial virus and influenza viruses in children during the second year of the COVID-19 pandemic - are non-pharmaceutical interventions as effective as vaccines?
    Kışlal FM; Hanilçe Y; Altaş B; Büyükbaşaran ZE; Güven D
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3777-3783. PubMed ID: 37140326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication.
    Tripp RA; Martin DE
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses.
    Carter DM; Darby CA; Johnson SK; Carlock MA; Kirchenbaum GA; Allen JD; Vogel TU; Delagrave S; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universally Immune: How Infection Permissive Next Generation Influenza Vaccines May Affect Population Immunity and Viral Spread.
    Bull MB; Cohen CA; Leung NHL; Valkenburg SA
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.